INTERNATIONAL STUDY SHOWS 3-YEAR BENEFITS OF GLAUKOS ISTENT® TRABECULAR MICRO-BYPASS STENT IN COMBINATION WITH CATARACT SURGERY
January 21, 2016The study, published in the Journal of Cataract and Refractive Surgery, reveals 36% reduction in mean IOP and 86% reduction in mean number of medications in patients with range of glaucoma type and progression.
More »
Allan L. Shaw Joins Syndax Pharmaceuticals As Chief Financial Officer
January 20, 2016Allan Shaw joins Syndax with more than 20 years of experience as a chief financial officer, industry executive and independent board member of public companies.
More »
Esperion Therapeutics Announces Initiation of Phase 3 Clinical Program With Long-Term Safety and Tolerability Study
January 13, 2016Esperion announced the start of a global Phase 3 study of bempedoic acid in patients with hyperlipidemia. This study will enable understanding of the 52-week safety profile of bempedoic acid. Top-line results are expected in the fourth quarter of 2017.
More »